Expression of seven herpes simplex virus type 1 glycoproteins (gB, gC, gD, gE, gG, gH, and gI): comparative protection against lethal challenge in mice

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Journal of Virology

• Publication date

  1994-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/jvi.68.4.2118-2126.1994PMID 8138996PMCID PMC236686
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immunoselection of recombinant baculoviruses expressing high levels of biologically active herpes simplex virus type 1 glycoprotein D

  2005cited by this paper
• Anti-glycoprotein B monoclonal antibody protects T cell-depleted mice against herpes simplex virus infection by inhibition of virus replication at the inoculated mucous membranes.

  1993cited by this paper
• The UL10 gene of herpes simplex virus 1 encodes a novel viral glycoprotein, gM, which is present in the virion and in the plasma membrane of infected cells

  1993cited by this paper
• Synergistic anti-HSV effect of tumor necrosis factor alpha and interferon gamma in human corneal fibroblasts is associated with interferon beta induction.

  1993cited by this paper
• Cytokine expression in vivo during murine herpetic stromal keratitis. Effect of protective antibody therapy.

  1993cited by this paper
• Identification and characterization of a novel herpes simplex virus glycoprotein, gK, involved in cell fusion

  1992cited by this paper
• A novel herpes simplex virus glycoprotein, gL, forms a complex with glycoprotein H (gH) and affects normal folding and surface expression of gH

  1992cited by this paper
• Expression of herpes simplex virus type 1 glycoprotein I in baculovirus: preliminary biochemical characterization and protection studies

  1992cited by this paper
• Expression of herpes simplex virus type 1 glycoprotein B in insect cells. Initial analysis of its biochemical and immunological properties.

  1992cited by this paper
• Differential mapping of Fc gamma-binding and monoclonal antibody-reactive epitopes on gE, the Fc gamma-binding glycoprotein of herpes simplex virus type 1.

  1992cited by this paper
• Baculovirus-expressed glycoprotein E (gE) of herpes simplex virus type-1 (HSV-1) protects mice against lethal intraperitoneal and lethal ocular HSV-1 challenge.

  1992cited by this paper
• Baculovirus-expressed glycoprotein G of herpes simplex virus type 1 partially protects vaccinated mice against lethal HSV-1 challenge.

  1992cited by this paper
• Baculovirus expressed herpes simplex virus type 1 glycoprotein C protects mice from lethal HSV-1 infection.

  1992cited by this paper
• Baculovirus-expressed glycoprotein H of herpes simplex virus type 1 (HSV-1) induces neutralizing antibody and delayed type hypersensitivity responses, but does not protect immunized mice against lethal HSV-1 challenge.

  1992cited by this paper
• Role of antibody-dependent cellular cytotoxicity in defense against herpes simplex virus infections.

  1991cited by this paper
• Cell surface expression of herpes simplex virus type 1 glycoprotein H in recombinant baculovirus-infected cells.

  1991cited by this paper
• Glycoprotein C of herpes simplex virus type 1 prevents complement-mediated cell lysis and virus neutralization.

  1990cited by this paper
• Herpes simplex virus type 1 encodes two Fc receptors which have different binding characteristics for monomeric immunoglobulin G (IgG) and IgG complexes

  1990cited by this paper
• Immunogenicity of herpes simplex virus type 1 glycoproteins expressed in vaccinia virus recombinants.

  1990cited by this paper
• Demonstration of MHC class II-restricted cytotoxic T lymphocytes in mice against herpes simplex virus.

  1990cited by this paper
• Modulation of acute and latent herpes simplex virus infection in C57BL/6 mice by adoptive transfer of immune lymphocytes with cytolytic activity

  1989cited by this paper
• C3b receptor activity on transfected cells expressing glycoprotein C of herpes simplex virus types 1 and 2

  1988cited by this paper
• Monoclonal antibodies define a domain on herpes simplex virus glycoprotein B involved in virus penetration

  1988cited by this paper
• Fine mapping of the latency-related gene of herpes simplex virus type 1: alternative splicing produces distinct latency-related RNAs containing open reading frames

  1988cited by this paper
• T4+ T helper cell function in vivo: differential requirement for induction of antiviral cytotoxic T-cell and antibody responses

  1988cited by this paper
• Antibody to cloned HSV glycoproteins B and D plus adult human leukocytes protect neonatal mice from lethal HSV infection.

  1988cited by this paper
• The complete DNA sequence of the long unique region in the genome of herpes simplex virus type 1.

  1988cited by this paper
• Mechanisms of antiviral immunity induced by a vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D: cytotoxic T cells

  1987cited by this paper
• Herpes simplex virus glycoproteins gC-1 and gC-2 bind to the third component of complement and provide protection against complement- mediated neutralization of viral infectivity

  1987cited by this paper
• Identification of a novel herpes simplex virus type 1-induced glycoprotein which complexes with gE and binds immunoglobulin

  1987cited by this paper
• Anti-glycoprotein D antibodies that permit adsorption but block infection by herpes simplex virus 1 prevent virion-cell fusion at the cell surface.

  1987cited by this paper
• Binding of complement component C3b to glycoprotein gC of herpes simplex virus type 1: mapping of gC-binding sites and demonstration of conserved C3b binding in low-passage clinical isolates

  1986cited by this paper
• An analysis of the biological properties of monoclonal antibodies against glycoprotein D of herpes simplex virus and identification of amino acid substitutions that confer resistance to neutralization.

  1986cited by this paper
• Specificity of human natural killer cells in limiting dilution culture for determinants of herpes simplex virus type 1 glycoproteins

  1986cited by this paper
• The properties and sequence of glycoprotein H of herpes simplex virus type 1.

  1986cited by this paper
• Glycoproteins Specified by Herpes Simplex Viruses

  1985cited by this paper
• Binding of complement component C3b to glycoprotein C is modulated by sialic acid on herpes simplex virus type 1-infected cells

  1985cited by this paper
• Specificities of monoclonal and polyclonal antibodies that inhibit adsorption of herpes simplex virus to cells and lack of inhibition by potent neutralizing antibodies

  1985cited by this paper
• Humoral Response to Herpes Simplex Virus Infections

  1985cited by this paper
• Co-cultivation versus blot hybridization for the detection of trigeminal ganglionic latency following corneal inoculation with HSV-1 strains of varying TK expression and pathogenicity.

  1984cited by this paper
• Immunogenicity of herpes simplex virus glycoproteins gC and gB and their role in protective immunity

  1984cited by this paper
• Detection of antibodies to herpes simplex virus with a continuous cell line expressing cloned glycoprotein D.

  1983cited by this paper
• Herpes simplex virus type-1 glycoprotein D gene: nucleotide sequence and expression in Escherichia coli.

  1982cited by this paper
• Role of Lyt‐1 Positive Immune T Cells in Recovery from Herpes Simplex Virus Infection in Mice

  1982cited by this paper
• A virion-associated glycoprotein essential for infectivity of herpes simplex virus type 1.

  1981cited by this paper
• Cell-mediated immunity to herpes simplex virus: specificity of cytotoxic T cells

  1980cited by this paper
• Cell-mediated immunity in herpes simplex virus-infected mice: induction, characterization and antiviral effects of delayed type hypersensitivity.

  1980cited by this paper
• Cell-mediated immunity in herpes simplex virus-infected mice: suppression of delayed hypersensitivity by an antigen-specific B lymphocyte.

  1980cited by this paper
• Cell-mediated immunity against herpes simplex induction of cytotoxic T lymphocytes

  1980cited by this paper
• Membrane proteins specified by herpes simplex viruses. III. Role of glycoprotein VP7(B2) in virion infectivity

  1979cited by this paper
• Possible role of Fc receptors on cells infected and transformed by herpesvirus: escape from immune cytolysis

  1978cited by this paper
• Glycoproteins specified by herpes simplex virus type 1: their synthesis, processing and antigenic relatedness to HSV -2 glycoproteins.

  1975cited by this paper
• Heterogeneity in the properties of 7 S and 19S rabbit-neutralizing antibodies to herpes simplex virus.

  1968cited by this paper

• The importance of IFNα2A (Roferon-A) in HSV-1 latency and T cell exhaustion in ocularly infected mice

  2024cites this paper
• Absence of CD80 reduces HSV-1 replication in the eye and delays reactivation but not latency levels

  2024cites this paper
• A novel GFP-based strategy to quantitate cellular spatial associations in HSV-1 viral pathogenesis

  2024cites this paper
• The anti-apoptotic function of HSV-1 LAT in neuronal cell cultures but not its function during reactivation correlates with expression of two small non-coding RNAs, sncRNA1&2

  2024cites this paper
• Presence of CD80 and Absence of LAT in Modulating Cellular Infiltration and HSV-1 Latency

  2024cites this paper
• Binding of herpesvirus entry mediator (HVEM) and HSV-1 gD affect reactivation but not latency levels

  2023cites this paper
• Stacking the odds: Multiple sites for HSV-1 latency

  2023cites this paper
• IL-17A expression by both T cells and non-T cells contribute to HSV-IL-2-induced CNS demyelination

  2023cites this paper
• Cell-to-cell spread inhibiting antibodies constitute a correlate of protection against herpes simplex virus type 1 reactivations: A retrospective study

  2023cites this paper
• Small Noncoding RNA (sncRNA1) within the Latency-Associated Transcript Modulates Herpes Simplex Virus 1 Virulence and the Host Immune Response during Acute but Not Latent Infection

  2022cites this paper
• Absence of signal peptide peptidase in peripheral sensory neurons affects latency-reactivation in HSV-1 ocularly infected mice

  2022cites this paper
• Blocking Autophagy in M1 Macrophages Enhances Virus Replication and Eye Disease in Ocularly Infected Transgenic Mice

  2022cites this paper
• Knockout of signal peptide peptidase in the eye reduces HSV-1 replication and eye disease in ocularly infected mice

  2022cites this paper
• Herpes Simplex Virus 1 Glycoproteins Differentially Regulate the Activity of Costimulatory Molecules and T Cells

  2022cites this paper
• Blocking HSV-1 glycoprotein K binding to signal peptide peptidase reduces virus infectivity in vitro and in vivo

  2021cites this paper
• Role of TH17 Responses in Increasing Herpetic Keratitis in the Eyes of Mice Infected with HSV-1

  2020cites this paper
• “Non-Essential” Proteins of HSV-1 with Essential Roles In Vivo: A Comprehensive Review

  2020cites this paper
• CD80 Plays a Critical Role in Increased Inflammatory Responses in Herpes Simplex Virus 1-Infected Mouse Corneas

  2019cites this paper
• Absence of Signal Peptide Peptidase, an Essential Herpes Simplex Virus 1 Glycoprotein K Binding Partner, Reduces Virus Infectivity In Vivo

  2019cites this paper
• The Absence of Lymphotoxin-α, a Herpesvirus Entry Mediator (HVEM) Ligand, Affects Herpes Simplex Virus 1 Infection In Vivo Differently than the Absence of Other HVEM Cellular Ligands

  2019cites this paper
• Roles of Type 1, 2, and 3 Innate Lymphoid Cells in Herpes Simplex Virus 1 Infection In Vitro and In Vivo

  2019cites this paper
• An M2 Rather than a TH2 Response Contributes to Better Protection against Latency Reactivation following Ocular Infection of Naive Mice with a Recombinant Herpes Simplex Virus 1 Expressing Murine Interleukin-4

  2018cites this paper
• Role of Herpes Simplex Virus Type 1 (HSV-1) Glycoprotein K (gK) Pathogenic CD8+ T Cells in Exacerbation of Eye Disease

  2018cites this paper
• Herpes Simplex Virus 1 Latency and the Kinetics of Reactivation Are Regulated by a Complex Network of Interactions between the Herpesvirus Entry Mediator, Its Ligands (gD, BTLA, LIGHT, and CD160), and the Latency-Associated Transcript

  2018cites this paper
• Herpes Simplex Virus 1 ICP22 Suppresses CD80 Expression by Murine Dendritic Cells

  2018cites this paper
• Roles of M1 and M2 Macrophages in Herpes Simplex Virus 1 Infectivity

  2017cites this paper
• Reply to “Highly Efficacious Novel Vaccine, Humoral Immunity, and Ocular Herpes Simplex Virus 1: Reality or Myth?”

  2017cites this paper
• Binding of Herpes Simplex Virus 1 UL20 to GODZ (DHHC3) Affects Its Palmitoylation and Is Essential for Infectivity and Proper Targeting and Localization of UL20 and Glycoprotein K

  2017cites this paper
• The Absence of DHHC3 Affects Primary and Latent Herpes Simplex Virus 1 Infection

  2017cites this paper
• Immunogenicity and Efflcacy of Baculovirus Derived Glycoprotein D of Herpes Simplex Virus Type-l in Mice

  2017cites this paper
• Highly Efficacious Novel Vaccine, Humoral Immunity, and Ocular Herpes Simplex Virus 1: Reality or Myth?

  2017cites this paper
• Interrelationship of Primary Virus Replication, Level of Latency, and Time to Reactivation in the Trigeminal Ganglia of Latently Infected Mice

  2016cites this paper
• Interrelationship of primary virus replication, level of latency and time to reactivate 1 in the trigeminal ganglia of latently infected mice

  2016cites this paper
• Age related seroepidemiological survey of measles, mumps, rubella, varicella zoster, herpes simplex type 1 and 2 viruses

  2015cites this paper
• Herpes Simplex Virus type 1 lytic viral gene expression during the establishment and maintenance of latency

  2015cites this paper
• Mutations within the Pathogenic Region of Herpes Simplex Virus 1 gK Signal Sequences Alter Cell Surface Expression and Neurovirulence

  2014cites this paper
• Inclusion of CD80 in HSV Targets the Recombinant Virus to PD-L1 on DCs and Allows Productive Infection and Robust Immune Responses

  2014cites this paper
• Role of CD8+ T Cells and Lymphoid Dendritic Cells in Protection from Ocular Herpes Simplex Virus 1 Challenge in Immunized Mice

  2014cites this paper
• Binding of HSV-1 Glycoprotein K (gK) to Signal Peptide Peptidase (SPP) Is Required for Virus Infectivity

  2014cites this paper
• Inhibitors of signal peptide peptidase (SPP) affect HSV-1 infectivity in vitro and in vivo.

  2014cites this paper
• A Replication Competent HSV-1(McKrae) with a Mutation in the Amino-terminus of Glycoprotein K (gK) is Unable to Infect Mouse Trigeminal Ganglia after Cornea Infection

  2014cites this paper
• Overexpression of herpes simplex virus glycoprotein K (gK) alters expression of HSV receptors in ocularly-infected mice.

  2014cites this paper
• Of mice and not humans: how reliable are animal models for evaluation of herpes CD8(+)-T cell-epitopes-based immunotherapeutic vaccine candidates?

  2011cites this paper
• Immunization with Different Viral Antigens Alters the Pattern of T Cell Exhaustion and Latency in Herpes Simplex Virus Type 1-Infected Mice

  2010cites this paper
• Ocular infection of mice with an avirulent recombinant HSV-1 expressing IL-4 and an attenuated HSV-1 strain generates virulent recombinants in vivo

  2010cites this paper
• Serological array for the diagnosis of viral infection of the central nervous system

  2010cites this paper
• Involvement of STAT4 in IgG subtype switching and ocular HSV-1 replication in mice

  2010cites this paper
• Exacerbation of corneal scarring in HSV-1 gK-immunized mice correlates with elevation of CD8+CD25+ T cells in corneas of ocularly infected mice.

  2010cites this paper
• Molecular Cloning and Sequence Analysis of the Duck Plague Virus gI Gene

  2010cites this paper
• Original Article Detection of Herpes Simplex Virus Antibodies Using the Whole Virus and Recombinant gD

  2009cites this paper
• The role of a glycoprotein K (gK) CD8+ T-cell epitope of herpes simplex virus on virus replication and pathogenicity.

  2009cites this paper
• Lymphoid-Related CD11c+ CD8α+ Dendritic Cells Are Involved in Enhancing Herpes Simplex Virus Type 1 Latency

  2008cites this paper
• Role of Dendritic Cells in Enhancement of Herpes Simplex Virus Type 1 Latency and Reactivation in Vaccinated Mice

  2008cites this paper
• Gender-Dependent HLA-DR-Restricted Epitopes Identified from Herpes Simplex Virus Type 1 Glycoprotein D

  2008cites this paper
• A Replication-Competent, Neuronal Spread-Defective, Live Attenuated Herpes Simplex Virus Type 1 Vaccine

  2008cites this paper
• Expression of the herpes simplex virus type 2 glycoprotein D in baculovirus expression system and evaluation of its immunogenicity in guinea pigs.

  2008cites this paper
• Protection of Chickens from Newcastle Disease and Infectious Laryngotracheitis with a Recombinant Fowlpox Virus Co-Expressing the F, HN Genes of Newcastle Disease Virus and gB Gene of Infectious Laryngotracheitis Virus

  2008cites this paper
• A Recombinant Herpes Simplex Virus Type 1 Expressing Two Additional Copies of gK Is More Pathogenic than Wild-Type Virus in Two Different Strains of Mice

  2007influential citation
• Role of anti-glycoproteins D (anti-gD) and K (anti-gK) IgGs in pathology of herpes stromal keratitis in humans.

  2007cites this paper
• A recombinant multivalent combination vaccine protects against Chlamydia and genital herpes.

  2007cites this paper
• Epitope mapping of HSV-1 glycoprotein K (gK) reveals a T cell epitope located within the signal domain of gK.

  2007cites this paper
• Macrophages are important determinants of acute ocular HSV-1 infection in immunized mice.

  2007cites this paper
• Induction of humoral and cellular immunity against latent HSV-1 infections by DNA immunization in BALB/c mice.

  2007cites this paper
• Purification of phocid herpesvirus type 1 glycoproteins B and D and pilot studies of immunogenicity in mice.

  2006cites this paper
• Immunogenicity and Efficacy of Baculovirus Derived Glycoprotein D of Herpes Simplex Virus Type-1 in Mice

  2006cites this paper
• The effect of DNA priming-protein boosting on enhancing humoral immunity and protecting mice against lethal HSV infections.

  2006cites this paper
• Pathogenicity and immunogenicity of equine herpesvirus type 1 mutants defective in either gI or gE gene in murine and hamster models.

  2006cites this paper
• Recombinant Herpes Simplex Virus Type 1 (HSV-1) Codelivering Interleukin-12p35 as a Molecular Adjuvant Enhances the Protective Immune Response against Ocular HSV-1 Challenge

  2005cites this paper
• Immunization with glycoprotein C of equine herpesvirus-1 is associated with accelerated virus clearance in a murine model

  2005cites this paper
• Immunotherapeutic activity of a recombinant combined gB-gD-gE vaccine against recurrent HSV-2 infections in a guinea pig model.

  2005cites this paper
• A soluble divalent class I MHC/IgG1 fusion protein activates CD8+ T cells in vivo.

  2005cites this paper
• Treatment of Mice with Anti-CD86 mAb Reduces CD8+ T Cell-Mediated CTL Activity and Enhances Ocular Viral Replication in HSV-1-Infected Mice

  2005cites this paper
• Immunogenicity of influenza and HSV-1 mixed antigen ISCOMs in mice

  2005cites this paper
• Expression and characterization of baculovirus expressed herpes simplex virus type 1 glycoprotein L

  2005cites this paper
• Deletion of the carboxy-terminus of herpes simplex virus type 1 (HSV-1) glycoprotein B does not affect oligomerization, heparin-binding activity, or its ability to protect against HSV challenge

  2005influential citation
• Prospects for Developing an Effective Vaccine Against Ocular Herpes Simplex Virus Infection

  2005cites this paper
• Glycoprotein D adjuvant herpes simplex virus vaccine

  2005cites this paper
• Varicella-zoster virus expressing HSV-2 glycoproteins B and D induces protection against HSV-2 challenge.

  2004cites this paper
• Improved protection from primary ocular HSV-1 infection and establishment of latency using multigenic DNA vaccines.

  2004cites this paper
• Involvement of CD8+ T-cells in exacerbation of corneal scarring in mice

  2004cites this paper
• Immunological properties of a DNA plasmid encoding a chimeric protein of herpes simplex virus type 2 glycoprotein B and glycoprotein D.

  2003cites this paper
• Intravascular naked DNA vaccine encoding glycoprotein B induces protective humoral and cellular immunity against herpes simplex virus type 1 infection in mice

  2003cites this paper
• Comparison of Adjuvant Efficacy of Herpes Simplex Virus Type 1 Recombinant Viruses Expressing TH1 and TH2 Cytokine Genes

  2003cites this paper
• Identification of Novel Immunodominant CD4+ Th1-Type T-Cell Peptide Epitopes from Herpes Simplex Virus Glycoprotein D That Confer Protective Immunity

  2003cites this paper
• IMMUNOGENICITY AND EFFICACY OF BACULOVIRUS DERIVED GLYCOPROTEIN D OF HERPES SIMPLEX VIRUS TYPE-1 IN MICE

  2003cites this paper
• Reduced severity of HSV-1-induced corneal scarring in IL-12-deficient mice.

  2002cites this paper
• Enhanced clearance of herpes simplex virus type 1 and reduced herpetic eye disease in STAT6 knockout mice is associated with increased IL-2.

  2002cites this paper
• High level expression and secretion of truncated forms of herpes simplex virus type 1 and type 2 glycoprotein D by the methylotrophic yeast Pichia pastoris.

  2002cites this paper
• Infection of BALB/c mice with a herpes simplex virus type 1 recombinant virus expressing IFN-gamma driven by the LAT promoter.

  2002cites this paper
• Enhanced protection against HSV lethal challenges in mice by immunization with a combined HSV-1 glycoprotein B:H:L gene DNAs.

  2002cites this paper
• Overexpression of Interleukin-2 by a Recombinant Herpes Simplex Virus Type 1 Attenuates Pathogenicity and Enhances Antiviral Immunity

  2002cites this paper
• Large‐scale comparison of experimental adjuvants with herpes simplex virus vaccine reveals a correlation of protection with IgG2a and IgG2b responses

  2002cites this paper
• A comparison of oral and parenteral routes for therapeutic vaccination with HSV-2 ISCOMs in mice; cytokine profiles, antibody responses and protection.

  2001cites this paper
• Recombinant Herpes Simplex Virus Type 1 Expressing Murine Interleukin-4 Is Less Virulent than Wild-Type Virus in Mice

  2001cites this paper
• Protection of chickens from infectious laryngotracheitis with a recombinant fowlpox virus expressing glycoprotein B of infectious laryngotracheitis virus

  2001cites this paper
• Infektionen mit Herpes Simplex — und Varizella Zoster Viren

  2001cites this paper
• Corneal macrophage infiltrates following ocular herpes simplex virus type 1 challenge vary in BALB/c mice vaccinated with different vaccines.

  2000cites this paper
• Both CD4+ and CD8+ T cells are involved in protection against HSV-1 induced corneal scarring

  2000cites this paper
• Natural infection with herpes simplex virus type 1 (HSV-1) induces humoral and T cell responses to the HSV-1 glycoprotein H:L complex.

  2000cites this paper
• Biolistic-mediated gene transfer using the bovine herpesvirus-1 glycoprotein D is an effective delivery system to induce neutralizing antibodies in its natural host.

  2000cites this paper